Korea University Uses AI to Find Potential Antiviral Compounds
Korea University researchers used AI and laboratory testing to identify potential inhibitors of a human enzyme involved in viral replication, the university said in a press release. The study was published online in the Journal of Cheminformatics on August 5, 2026.
The team benchmarked 13 machine learning models and 10 molecular generation methods using deoxyhypusine synthase, or DHPS, as the target. DHPS supports a cellular process used in the replication of several viruses.
Researchers selected six AI generated molecular fragments for laboratory tests, including three predicted to be active and three predicted to be inactive. All three predicted active fragments inhibited DHPS, while the other three did not. Two active fragments had measurable IC50 values of 31.2 and 49.1 μM, and an X ray co crystal structure showed one compound binding near the enzyme's substrate and NAD binding pocket. The researchers described the compounds as early stage hits rather than drug candidates.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 19 EchoNous Releases Torso NXT Ultrasound Probe in US Oct 19 Fabarta Upgrades AI for Science Platform With RSI Engine Oct 19 Notable Introduces Flow Compass for Healthcare AI Workflows Oct 19 MegaRobo Launches AI Protein Design Competition Oct 19 Helfie AI and Health Innovation South West to Test Smartphone Hypertension ScreeningLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Tsingke Introduces Validation Workflow for AI Designed Proteins
ARPA-H Funds $28.6 Million AI Protein Research Project
Seven South Korean Financial Firms Hit by Suspected AI Assisted Hacks
Hansa Biopharma Partners With Cradle on AI Protein Design
Anthropic Says Claude Identified an Uncharacterized Enzyme System
Daily AI Brief: the AI news that matters, in your inbox.